Elena Dmitrieva

7PUBLICATIONS
44CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Respiratory diseasesCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 19, 2026
Minimal residual disease-guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype.

|Aug 10, 2026
Allogeneic Stem Cell Transplantation-A Salvage Option for High-Risk Chronic Lymphocytic Leukemia Patients: A 15-Year Single-Center Experience.

|Feb 20, 2026
[Characteristics and 5-year outcomes in patients with chronic lymphocytic leukemia receiving ibrutinib (a real-world study)].

U P Ergasheva, E P Panchenko, C G Chernyshenko

|May 18, 2023
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.

Eugene Nikitin, Maria Kislova, Dmitry Morozov

|Apr 14, 2023
Significant reduction in the incidence of non-coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID-19 pandemic: An additional benefit of lockdown.

Maria Kislova, Andrei Petrenko, Elena A Dmitrieva

|Feb 14, 2022
COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study.

Оlga L Kochneva, Maria Kislova, Evgenya I Zhelnova

Pageof 2

Frequent Collaborators

6 joint publications

Maria Kislova

4 joint publications

Eugene Nikitin

4 joint publications

Vadim V Ptushkin

2 joint publications

Andrey Sudarikov